Medical/Pharmaceuticals

ASC40 (TVB-2640) Significantly Reduced Liver Fat With a 61% Responder Rate in Phase 2 NASH Trial

HANGZHOU, China and SHAOXING, China, June 17, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today that its partner Sagimet Biosciences Inc (Sagimet, formerly 3-V Biosciences Inc), announced today positive results on oral, once-daily non-alcoholic steatohepatitis (NASH) dru...

2020-06-17 20:30 3269

InDevR Delivers Commercial Multiplex Coronavirus SeroAssay Kit and Testing Services for Vaccine Development

BOULDER, Colorado, June 17, 2020 /PRNewswire/ -- InDevR, Inc., a leader in novel analytical technologies that support the development and production of vaccines and biotherapeutics, announced commercial availability of its COVID-19 serology test kits. InDevR's VaxArray Coronavirus SeroAssay lever...

2020-06-17 20:00 1527

CNBC Names Contactless Vitals Startup Neteera to Disruptor 50 List

JERUSALEM, June 17, 2020 /PRNewswire/ -- Neteera , global leader in contactless vital signs sensing, has been ranked ninth in CNBC's annualDisruptor 50 list of 50 private companies whose innovations are revolut...

2020-06-17 19:11 2268

Think City Survey Shows That Malaysian Women and Youth Experience Higher Levels of Stress During MCO

KUALA LUMPUR, Malaysia, June 15, 2020 /PRNewswire/ -- A recent survey conducted by Think City, a social purpose organisation for urban rejuvenation, has revealed that women and those aged 18-24 experienced higher levels of stress compared to other demographic profiles during the recent Movement C...

2020-06-17 16:48 2132

Viva BioInnovator (VBI) Successfully Held 1st Demo Day

SHANGHAI, June 15, 2020 /PRNewswire/ -- On 11 June 2020, Viva BioInnovator (VBI) successfully held its 1st Demo Day e-congress. Among nearly 50 incubation portfolio companies from the VBI platform, 8 startup companies attended this event, namely Forkhead Bio Therapeutics, DTx Pharma, Epican Techn...

2020-06-17 16:40 2215

Olympus Launches the Soltive SuperPulsed Thulium Fiber Laser System for Urology

HAMBURG, Germany and TOKYO, June 17, 2020 /PRNewswire/ -- Olympus®, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announces the commercial launch of the Soltive™ SuperPulsed Laser System (Soltive Laser System), a new application o...

2020-06-17 15:00 1786

Ascentage Pharma Announces First Patient Dosed in the Phase II Clinical Study of IAP Antagonist APG-1387 in Combination with Entecavir for the Treatment of Patients with Chronic Hepatitis B

SUZHOU, China, and ROCKVILLE, MD., June 17, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the Phase II clinical ...

2020-06-17 13:20 2474

NCCN Works to Improve Global Cancer Care for Children with Newly Translated Recommendations

NCCN Guidelines for Pediatric Acute Lymphoblastic Leukemia in Chinese, Japanese, French, Spanish, and Portuguese are now available for free at NCCN.org PLYMOUTH MEETING, Pa., June 17, 2020 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in ...

2020-06-17 08:35 3079

DERMALOG Contactless Fever Checks at Medical Practices

HAMBURG, Germany, June 16, 2020 /PRNewswire/ -- With its Fever Detection Camera, DERMALOG has developed a solution that measures body temperatures fast and accurately when walking by. This can significantly reduce the risk of infection spreading. German 'Practice without Limits' has chosen theHam...

2020-06-16 21:30 1438

Immunexpress Awarded BARDA Contract to Develop SeptiCyte® RAPID for COVID-19 Patient Triage

SEATTLE, June 16, 2020 /PRNewswire/ -- Immunexpress, Inc., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, has been awarded a grant from the Biomedical Advanced Research and Development Authority ("BARDA"), part of the Office of the Assistant Secretary ...

2020-06-16 20:00 1040

Saiba AG Selects AGC Biologics to Develop and Produce COVID-19 Vaccine

AGC Biologics will manufacture SARS-CoV-2 vaccine for partner Saiba AG SEATTLE, June 16, 2020 /PRNewswire/ -- AGC Biologics, a global biopharmaceutical Contract Development Manufacturing Organization (CDMO), has announced it will be partnering withSaiba AG to manufacture a SARS-CoV-2 vaccine to ...

2020-06-16 19:00 2742

Team Hollo from the University of Hong Kong wins 2020 Microsoft Imagine Cup World Champion

HONG KONG, June 16, 2020 /PRNewswire/ -- Team Hollo, an iDendron incubatee from theUniversity of Hong Kong (HKU), won the 2020 Microsoft Imagine Cup World Champion with a mental health platform connecting a mobile app for users and a web application for mental health professionals; leveraging the...

2020-06-16 17:26 2885

Rhenus Delivers Over 200 Million Essential Medical Supplies to Support COVID-19 Relief Efforts in Asia and Europe

SINGAPORE, June 16, 2020 /PRNewswire/ -- The Rhenus Group taps on its extensive and robust supply chain network to support COVID-19 relief efforts across borders. Logistics teams inAsia work seamlessly together to help customers deliver essential medical supplies, despite supply chain challen...

2020-06-16 14:51 1869

ChromaDex Commits to COVID-19 Research Following Promising Initial Preclinical Findings Showing Viral Infections Deplete NAD and SARS-CoV-2-Infected Cells Activate NAD Defense Pathway That Utilizes Nicotinamide Riboside (NR)

LOS ANGELES, June 16, 2020 /PRNewswire/ -- ChromaDex Corp. (NASDAQ:CDXC), a global scientific authority on nicotinamide adenine dinucleotide (NAD) and innovators behind Niagen® (patented nicotinamide riboside) science, announced today the publication of results from preclinical research on cells ...

2020-06-16 14:09 7108

Medit Celebrates 20th Anniversary and Appoints GB (Gyu Bum) Ko as New CEO to Accelerate Growth Strategy

SEOUL, South Korea, June 16, 2020 /PRNewswire/ -- Medit announces the nomination of its new Chief Executive Officer, GB (Gyu Bum) Ko, amidst the company's 20th year as a global provider of 3D scanning solutions. Ko joins Medit to accelerate its growth strategy as a leader in the dental clinics an...

2020-06-16 12:47 2912

New Capture the Fracture® Partnership Aims for 25% Reduction in the Incidence of Hip and Vertebral Fractures Due to Osteoporosis by 2025

International Osteoporosis Foundation Announces First-of-its-kind Partnership WithUniversity of Oxford, Amgen and UCB to Combat Global Public Health Burden of Osteoporosis[1] Hip and Vertebral Fractures are Costly for Society and Can be Life-Altering for Patients[2],[3] NYON, Switzerland...

2020-06-16 08:00 3123

WuXi Biologics (Suzhou) Received EMA GMP Certificate for Biosafety Testing

* One of few third-party biosafety testing providers certified by EMA GMP standards inChina even Asia-Pacific region SUZHOU, China, June 16, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that its f...

2020-06-16 08:00 2760

Epredia and Lunaphore Announce Commercial Agreement for Exclusive Distribution of LabSat® Research

PORTSMOUTH, New Hampshire and LAUSANNE, Switzerland, June 15, 2020 /PRNewswire/ -- Epredia , a global leader in precision cancer diagnostics and tissue diagnostics, and Lunaphore Technologies SA, a Swiss life-sciences company developing innovative next-generation equipment f...

2020-06-15 20:00 1640

PolyU collaborates with Macau University of Science and Technology to advance diagnosis of COVID-19 pneumonia

HONG KONG, June 15, 2020 /PRNewswire/ -- COVID-19 is taking its toll on the world, affecting more than 200 countries and regions. In the face of a surge in cases, rapid diagnosis and identification of high-risk patients for early intervention is crucial for controlling the pandemic. The Hong Kong...

2020-06-15 18:22 2104

Investigational, Once-weekly Insulin Icodec Showed Comparable Efficacy and Safety to Once-daily Insulin Glargine U100 in Phase 2 Trial

This material is intended for global medical media only, excl US  For journalistic assessment and preparation before publication.  BAGSVÆRD, Denmark, June 15, 2020 /PRNewswire/ -- Today, Novo Nordisk announced results from a phase 2 clinical trial of investigational insulin icodec, a once-week...

2020-06-15 07:30 1465
1 ... 556557558559560561562 ... 608